DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:30 PM.
Here’s what investors need to know about the announcement.
Earnings
DiaMedica Therapeutics beat estimated earnings by 27.78%, reporting an EPS of $-0.13 versus an estimate of $-0.18.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 2.82% increase in the share price the next day.
To track all earnings releases for DiaMedica Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
